NCT00850421终止不适用
A Single-Center Pharmacoeconomic Pilot Study of BOTOX® (Botulinum Toxin Type A) for the Prophylactic Treatment of Migraine Headaches
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- To Determine Whether Resource Utilization is Decreased in Subjects Treated With BOTOX Injections for Episodic Migraine Headache.
研究概览
简要总结
The purposes of this study are to assess whether subjects treated with BOTOX will:
- have a decrease in the frequency and intensity of migraine headaches
- experience improvements in quality of life
- experience a reduction in the frequency of health care services obtained.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects > 18 years of age
- •Subject has an established history of migraine headache, with or without aura, per IHS criteria (1.2.1 or 1.1), for at least 6 months prior to screening.
- •Subject receives primary health care from Park Nicollet Health Services.
排除标准
- •Subject has received previous injections of botulinum toxin of any serotype for any reason, within the 6 months prior to study participation.
- •Additional eligibility will be discussed at point of contact
研究组 & 干预措施
Botulinum Toxin Type A
Other
干预措施: Botulinum Toxin Type A (Drug)
结局指标
主要结局
To Determine Whether Resource Utilization is Decreased in Subjects Treated With BOTOX Injections for Episodic Migraine Headache.
时间窗: 190 days
次要结局
- To Assess the Effect of BOTX Injections on the Frequency and Intensity of Migraine Episodes in Subjects With Episodic Migraine Headache.(190 days)
- To Determine Whether Quality of Life is Improved in Subjects Treated With BOTOX Injections for Episodic Migraine Headache.(190 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel SyndromeCarpal Tunnel SyndromeNCT02070302Benjamin Sucher10
已完成
不适用
516-BOTOX Urinary Incontinence DetrusorUrinary IncontinenceUrinary Bladder, OveractiveNCT00850733Veterans Medical Research Foundation
已完成
1 期
Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular PainRefractory Cervicothoracic Myofascial Pain Syndrome (CMPS)Cervical DystoniaNCT00178945Vanderbilt University20
撤回
3 期
BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic MigraineMigraine DisordersNCT03193346Allergan
已完成
2 期
Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown LinesFrown LinesNCT04763265Croma-Pharma GmbH208